IRIS
GHIGLIOTTI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.037
AS - Asia 42
SA - Sud America 9
NA - Nord America 2
Totale 18.090
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.037
CN - Cina 36
BR - Brasile 7
VN - Vietnam 3
AR - Argentina 2
SG - Singapore 2
US - Stati Uniti d'America 2
KZ - Kazakistan 1
Totale 18.090
Salva come PNG Salva come JPEG
Città #
Genova 10.648
Genoa 4.261
Rapallo 1.864
Vado Ligure 1.217
Bordighera 46
Beijing 13
Boardman 2
Aparecida de Goiânia 1
Bạc Liêu 1
Goiânia 1
Guarulhos 1
Hanoi 1
Ho Chi Minh City 1
Igaporã 1
Kostanay 1
Limeira 1
Recife 1
San Juan 1
Santa Clara del Mar 1
Água Azul do Norte 1
Totale 18.064
Salva come PNG Salva come JPEG
Nome #
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 203
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 196
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 195
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 195
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols. 195
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 178
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 173
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 170
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 161
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 161
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 161
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 160
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 159
Carvedilol Prevents Doxorubicin-induced Free Radical release and Oxidative Damage in Cardiomyocytes. 157
Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. 156
Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development 156
N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of NewZealand white rabbits 155
Increased neutrophil lifespan in patients with congestive heart failure. 153
Aurintricarboxylic Acid attenuates intimal thickening after balloon injury of the rabbit aorta. 152
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 151
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 150
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 150
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 150
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 148
Protective effects of Resveratrol in an experimental model of abdominal aortic aneurysm induction. 148
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 146
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway 145
Thrombolysis in refractory unstable angina. 143
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 143
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 143
Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6. 139
Arterial hypertension in cancer: The elephant in the room 138
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 137
Associazione tra lipoperossidazione ed insorgenza giovanile di aterosclerosi coronarica. 137
Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes 135
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 134
Clinical stabilization of patients with unstable angina treated with thrombolytic therapy. 133
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 132
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 131
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline 131
Pigmented nodular melanoma: The predictive value of dermoscopic features using multivariate analysis 129
Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. 127
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 127
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 126
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 125
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 125
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 124
ADVANCED ABDOMINAL AORTIC ANEURYSMS DISPLAY ASPECIFIC INFLAMMATORY-PROATHEROSCLEROTIC PROFILEWITH RENAL DYSFUNCTION, RAISED D-DIMER, EXPANDEDCD14++CD16+-MONOCYTES HAVING HIGH CD143 124
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 121
Early Age of onset of unstable angina is associated to major oxidative stress 121
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 121
Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina. 120
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction 120
Prolonged activation of prothrombin on the vascular wall after arterial injury. 119
ERGONOVINE MALEATE TEST DETECTS ANGINAL PATIENTS WITH POORLY REPRODUCIBLE EXERCISE TESTS. 119
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 118
CD14CD16 monocyte subset levels in heart failure patients. 118
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 116
Pruritus characteristics in a large Italian cohort of psoriatic patients 116
Aspirin, but not heparin attenuates Xa/Va assembly after deep arterial injury of the rabbit aorta. 115
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 115
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 115
HETEROGENEITY AND DIFFERENT RELATIONSHIP WITH BIOCHEMICAL AND INFLAMMATORY BIOMARKERS FOR THE CIRCULATING CD16+ MONOCYTES SUBSETS IN ABDOMINAL AORTIC ANEURYSMS (AAA) 114
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 114
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 113
Systemic vascular inflammation in abdominal aortic aneurysm patients: a contrast-enhanced PET/CT study 112
Role of cell-cell bond for the viability and the function of vascular smooth muscle cells. 112
N-acetyl-cysteine Regulates the Response to Injury in NZW Rabbit Aorta. 112
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 112
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 112
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 110
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 109
PROGENITOR CD34+ CELLS AND CIRCULATING ENDOTHELIAL CELLS IN PATIENTS WITH ACUTE OR CHRONIC HEART FAILURE 109
ALTERAZIONI DELLE PROTEINE TELOMERICHE E SENESCENZA: UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ DA ANTRACICLINE 109
Gallopamil and diltiazem: a double-blind, randomized, cross-over trial in effort ischaemia. 108
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 108
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 105
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 104
LA DOXORUBICINA ALTERA L’ESPRESSIONE DELL’IGF-1R E DELL’IGFBP3 IN CELLULE MUSCOLARI CARDIACHE. UN NUOVO MECCANISMO DI CARDIOTOSSICITÀ 104
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 103
Carbon nanotubes biocompatibility with Cardiac muscle cells 103
Decreased Neointimal Proliferation by Inhibition of von Willebrand Factor Function 102
Early age of onset of unstable angina is associated with major oxidative stress 101
Identification of High-Risk Patients With Unstable Angina 101
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 101
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 100
Arresto Cardiaco Extraospedaliero: esperienza della Centrale Operativa 118 Genova Soccorso. 99
Two Takayasu arteritis patients successfully treated with rituximab. 99
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 98
Platelet-dependent and procoagulant mechanisms in arterial thrombosis. 97
Plasma Levels of Matrix metalloproteinase-2 are increased in plasma of patients with heart failure. 97
Peaking time of CK-MB in patients treated with thrombolytic agents during myocardial infarction: is it really a clue to reperfusion? 96
PROGNOSTIC VALUE OF BIPHASIC RESPONSE DURING DOBUTAMINE STRESS ECHO AFTER MYOCARDIAL-INFARCTION 95
Repeated balloon injury of the rabbit aorta increases thrombin binding and platelet deposition. 94
Cardiologia 1992. Angina Instabile: Criteri Clinici, strumentali, bioumorali per individuare i pazienti a più alto rischio 93
Detection of silent myocardial ischemia by repeated exercise tests in patients with stable effort angina 93
Thrombolytic therapy in refractory unstable angina: the role of Holter monitoring. 92
New therapeutic strategies in the management of congestive heart failure. 92
Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy 92
Effects of the AhR inhibitor CH-223191 on the indoxyl sulphateinduced cardiac fibroblast activation. Role of Nrf2 91
Totale 12.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.804
article - articoli 48.468
book - libri 819
conference - conferenze 7.742
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 775
Totale 115.608
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021613 0 0 0 80 23 69 20 71 108 94 71 77
2021/20222.033 26 183 176 264 91 95 102 508 50 183 75 280
2022/20232.232 229 121 15 244 416 377 22 187 359 15 210 37
2023/2024939 38 128 14 99 87 187 53 75 80 13 49 116
2024/20252.958 93 223 93 220 414 301 272 441 96 135 280 390
2025/20261.327 621 117 244 345 0 0 0 0 0 0 0 0
Totale 18.203